Silk Road Medical Inc. said certain selling stockholders will be offering 3.5 million of its common shares in an underwritten public offering.
The selling stockholders expect to grant the underwriters an option to buy up to an additional 525,000 common shares.
Silk Road Medical will not receive any proceeds from the sale of its common shares being offered by the selling stockholders.
J.P. Morgan Securities LLC and Bank of America Merrill Lynch are acting as joint book-running managers, and BMO Capital Markets and Stifel are acting as co-managers for the offering.
Silk Road is a medical device company with a key focus on reducing the risk of stroke.